London · Delayed Price · Currency is GBP · Price in GBX Chemring Group Earnings Call Transcripts
Fiscal Year 2025
-
Record order book and strong cash generation marked FY 2025, with revenue and margins up despite UK order delays. Expansion projects and acquisitions support growth, while robust order cover and rising defense spending underpin a positive outlook.
-
Record order intake and a robust GBP 1.3 billion order book drove 5% revenue and 8% operating profit growth, with strong performance in countermeasures and energetics. Guidance for FY2025 is unchanged, supported by high order cover and continued investment in capacity and innovation.
Fiscal Year 2024
-
Record order intake and order book drove 8% revenue growth, with strong performance in Energetics and Sensors & Information segments. Operational challenges in U.S. Countermeasures impacted margins, but robust cash generation and significant grant funding support future expansion.
-
Revenue rose 8% to GBP 223 million, with a record order book up 39% year-over-year and strong cash conversion. Operational challenges impacted margins, but robust demand and grant-funded capacity expansions support an unchanged, confident outlook for growth.